Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs LCID✓SelectedUSD · LCIDGSK vs LCID performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs LCID

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+7.3%
LCID return
-80.1%
Excess return
+87.4%
Maximum drawdown
-22.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioLCIDExcessAlpha
1D-0.1%-10.4%+10.3%+0.4%
7D-5.3%-15.4%+10.1%-4.5%
30D-3.7%-22.1%+18.5%-2.6%
3M-7.3%-55.6%+48.3%-3.7%
6M-4.2%-56.0%+51.7%-1.6%
YTD+0.9%-76.3%+77.2%+7.5%
1Y+7.3%-78.7%+85.9%+15.4%
All+7.3%-80.1%+87.4%+15.4%

Cumulative growth

Daily Returns

Daily percentage return beside LCID.

Daily Out/Under-Performance

Portfolio return minus LCID return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × LCID return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded LCID wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling